AUG 10, 2017 10:03 AM PDT

Probiotics: The Next Generation

WRITTEN BY: Kerry Evans

Evidently, we’ve entered the next generation of probiotics. From what I gather, next-generation probiotics are rationally designed to produce some desired effect - combat pathogens, for instance.

Researchers at Baylor College of Medicine found that the probiotic bacterium Lactobacillus reuteri produces an antimicrobial called reuterin, and this compound is able to kill Clostridium difficile. Interestingly, L. reuteri generates reuterin simply by fermenting glycerol.

Probiotics may be able to combat C. difficile

Image: Micropia

People most often become infected with C. difficile after the prolonged use of antibiotics, wiping out their resident gut microbes and making way for C. difficile. Often, traditional antibiotics aren’t enough to control the infection. Thus, researchers are looking for other ways to prevent and control this pathogen.

According to study author Jennifer K. Spinler, “when repeated antibiotic treatments fail to eliminate C. difficile infections, some patients are resorting to fecal microbiome transplant -- the transfer of fecal matter from a healthy donor -- which treats the disease but also could have negative side effects. We wanted to find an alternative treatment, a prophylactic strategy based on probiotics that could help prevent C. difficile from thriving in the first place."

First, the team at Baylor looked for a probiotic strain of Lactobacillus that was resistant to the antibiotics used to treat C. difficile infections. After all, it’s no use if your probiotic bites the dust. Luckily, they identified two strains of L. reuteri that survived treatment with vancomycin, metronidazole, and fidaxomicin.

Next, they wanted to know if these strains could produce reuterin and kill C. difficile. Both strains of L. reuteri inhibited the growth of C. difficile in an agar plate-based assay. However, mutant L. reuteri that could not produce reuterin did not kill C. difficile, indicating that C. difficile was susceptible to reuterin.

Then, they validated their findings with human fecal mini-bioreactor arrays. These bioreactors help model what happens in the gut when C. difficile invades. When they added both L. reuteri and glycerol (required to make reuterin) to the bioreactors, the level of C. difficile was 105-fold lower than controls! Treatment with L. reuteri alone (no glycerol) or glycerol alone, however, did not decrease the amount of C. difficile. Interestingly, adding reuterin alone also had no effect on C. difficile, indicating that the presence of live L. reuteri cells is important.

Finally, they treated germ-free mice with L. reuteri and glycerol and applied the animals’ cecal contents to C. difficile. They wanted to see if the cecal contents (presumably containing reuterin) could inhibit this pathogen’s germination and growth. When the mice were treated with both L. reuteri and glycerol, the cecal contents inhibited C. difficile growth by 104-fold. If the mice were treated only with glycerol or L. reuteri, however, C. difficile was able to grow.

According to co-author Jennifer Auchtung, “although these results are too preliminary to be translated directly into human therapy, they provide a foundation upon which to further develop treatments based on co-administration of L. reuteri and glycerol to prevent C. difficile infection.”

Sources: Science Daily and Infection and Immunity

 

About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
SEP 16, 2021
Microbiology
Medication May Build Up in Gut Bacteria, Impacting the Drug & Microbiome
SEP 16, 2021
Medication May Build Up in Gut Bacteria, Impacting the Drug & Microbiome
Gut microbes are crucial to our health. They aid in the digestion of food and absorption of nutrients. But they can also ...
OCT 21, 2021
Microbiology
Ongoing Salmonella Outbreak Traced to Onions
OCT 21, 2021
Ongoing Salmonella Outbreak Traced to Onions
On October 20, 2021, the Centers for Disease Control and Prevention (CDC) announced that an outbreak of Salmonella food ...
NOV 04, 2021
Immunology
The Coronavirus Infects Inner Ear Cells
NOV 04, 2021
The Coronavirus Infects Inner Ear Cells
An increasing number of COVID-19 patients have reported ear-related issues: ringing in the ear, hearing loss, and balanc ...
NOV 22, 2021
Microbiology
Researchers Solve the Structure of the HIV Capsid, May Be a New Drug Target
NOV 22, 2021
Researchers Solve the Structure of the HIV Capsid, May Be a New Drug Target
Though treatments are available, there is no cure or vaccine from HIV, which impacts about 38 million people worldwide. ...
NOV 28, 2021
Cell & Molecular Biology
Scientists Gain Insight Into How Bacteria Become Resistant to Drugs
NOV 28, 2021
Scientists Gain Insight Into How Bacteria Become Resistant to Drugs
Bacteria can swap genetic material with one another easily; one way they do it is a process called bacterial conjugation ...
NOV 30, 2021
Immunology
Sweet Escape: A Sugar Molecule Helps HIV Remain Incognito
NOV 30, 2021
Sweet Escape: A Sugar Molecule Helps HIV Remain Incognito
HIV is a master of disguise. Once the virus enters the body, it has a number of sophisticated mechanisms through which i ...
Loading Comments...